My main research interests are in understanding how therapies alter brain activity and in developing methodologies to measure these changes in both healthy individuals and patient groups. My previous studies have involved a range of compounds including hallucinogens (ketamine, LSD, psilocybin), anaesthetics (propofol, dexmedetomidine), anti-epileptics (vigabatrin, perampanel, tiagabine) and GABA-enhancers (zolpidem, gaboxadol). My research has used a wide-range of neuroimaging techniques including magnetoencephalography, electroencephalography, functional magnetic resonance imaging and magnetic resonance spectroscopy.

Examples of current research projects include:

1. Studying the effects of microdoses of LSD on brain and behaviour
2. Brain imaging the effects of ketamine in treatment-resistant depression
3. The use of rapid transcranial magnetic stimulation in treatment-resistant depression
4. The effects of scopolamine in depression

I completed my PhD in psychology at the University of Auckland in 2005 after which he joined the newly established Cardiff University Brain Research Imaging Centre as a post-doctoral fellow. In 2014 I received a Rutherford Discovery Fellowship and returned to Auckland to work The School of Pharmacy. I have an extensive network of scientific and clinical collaborators in both New Zealand and the United Kingdom.

For more information on my research and publications, click HERE

For contact details click HERE